HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rigmor Solberg Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

1/2020Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial.
1/2020Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rigmor Solberg Research Topics

Disease

5Neoplasms (Cancer)
12/2022 - 01/2010
3Atherosclerosis
01/2020 - 01/2017
2Neurodegenerative Diseases (Neurodegenerative Disease)
12/2022 - 11/2019
2Carotid Artery Diseases
01/2020 - 01/2017
2Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 01/2020
2Atherosclerotic Plaque (Atheroma)
01/2017 - 07/2014
2Colorectal Neoplasms (Colorectal Cancer)
07/2014 - 01/2013
2Pathologic Processes
04/2013 - 01/2013
2Neoplasm Metastasis (Metastasis)
04/2013 - 01/2010
1Fibrosis (Cirrhosis)
12/2022
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
12/2022
1Reperfusion Injury
01/2022
1Type 2 Diabetes Mellitus (MODY)
01/2020
1ST Elevation Myocardial Infarction
01/2020
1Myocardial Infarction
01/2020
1Stroke (Strokes)
01/2020
1Acute Coronary Syndrome
01/2020
1Osteoporosis
11/2019
1Peptic Ulcer (Peptic Ulcers)
08/2019
1Carotid Stenosis (Carotid Artery Stenosis)
01/2017
1Postmenopausal Osteoporosis
01/2017
1Pathologic Constriction (Stenosis)
01/2017
1Hypercholesterolemia
01/2014
1Myotoxicity
01/2014
1Melanoma (Melanoma, Malignant)
01/2010
1Breast Neoplasms (Breast Cancer)
01/2010
1Sepsis (Septicemia)
03/2003
1Staphylococcal Infections
05/2002

Drug/Important Bio-Agent (IBA)

11asparaginylendopeptidase (legumain)IBA
12/2022 - 01/2010
7Cysteine Proteases (Cysteine Protease)IBA
01/2020 - 01/2010
2ProdrugsIBA
08/2019 - 07/2014
1Complement System Proteins (Complement)IBA
01/2022
1Proton Pump InhibitorsIBA
08/2019
1EnzymesIBA
01/2017
1Biomarkers (Surrogate Marker)IBA
01/2017
1ImmunosorbentsIBA
01/2017
1Glucose (Dextrose)FDA LinkGeneric
01/2014
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2014
1Simvastatin (Zocor)FDA LinkGeneric
01/2014
1Peptide Hydrolases (Proteases)FDA Link
01/2013
1Histones (Histone)IBA
01/2013
1Cathepsin BIBA
01/2010
1Cystatin MIBA
01/2010
1matrigelIBA
01/2010
1CathepsinsIBA
01/2010
1Cystatin CIBA
01/2010
1Cysteine Proteinase InhibitorsIBA
01/2010
1LipopolysaccharidesIBA
03/2003
1CytokinesIBA
05/2002

Therapy/Procedure

1Percutaneous Coronary Intervention
01/2020